Key facts
- It has raised $19.3M; the latest was Later Stage VC in Nov 2025.
- Notable investors include CDTI Innvierte, COREangels Climate, Bertrand Jelensperger, Firstech Ventures, Francois Nuyts — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Luda Partners
- ·The full record, as it builds
Funding rounds
No funding rounds for Luda Partners are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Luda Partners
Developer of a neural network system intended to connect the pharmacy and the patient. The company's system integrates with pharmacy management tools that interrelate between laboratories, pharmacies, and end customers, enabling clients to locate medicines and reduce shortages, as well as provide information about the availability.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2017
- Employees
- 46
- Website
- ludapartners.com/
- Ownership
- Privately Held (backing)
Luda Partners doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Luda Partners shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Luda Partners in its N-PORT filings yet. We sweep new filings monthly.